TABLE 2

Bivariate Analysis of SHS-Exposed Patients Compared With Non–SHS-Exposed Patients Among Children Admitted for Acute Asthma Exacerbation

VariableSHS Exposed, n = 258, 41%Not SHS Exposed, n = 365, 59%P
Gender, %.77
 Male6062
 Female4038
Race/Ethnicity, %<.0001
 Black5031
 White2625
 Hispanic1834
 Other510
Age, median, y6.05.0.47
Insurance, %<.01
 Medicaid7967
 Private1932
 Self/other21
Prematurity, %.17
 Yes139
 No/not documented8791
History of asthma, %.18
 Yes7974
 No2126
Taking ICS at home, %.91
 No5050
 Yes5050
Concurrent PNA, %.71
 No8887
 Yes1213
Concurrent bronchiolitis, %.42
 No9496
 Yes64
PICU, %.10
 No7883
 Yes2217
EzPAP or CPAP, %.55
 No8789
 Yes1311
Oxygen, %.19
 No2925
 Yes7175
Magnesium, %.30
 No7578
 Yes2522
IV steroids, %.01
 No6575
 Yes3525
LOS, geometric mean (95% CI)50.0 (46.7–54.0)45.8 (43.4–48.4).02
  • ICS, inhaled corticosteroids.